Pilianidis, G., Papanastasiou, G. ., Tikoudi, P. ., Themistocleous, A. ., Farmakis, G. ., & Dolianitis, K. . (2024). Can euglycemic diabetic ketoacidosis caused by SGLT2 inhibitors be avoided in COVID-19 and other acute infections?. European Journal of Case Reports in Internal Medicine, 11(3). https://doi.org/10.12890/2024_004282